01—Abstract
Summary
Summary of the 8-K filed November 17, 2025. Cited figures are marked; the original filing is the authoritative source.
Charles River Laboratories International, Inc. (Company) disclosed in a Current Report on Form 8-K under Item 8.01 (Other Events) that the U.S. Securities and Exchange Commission's Division of Enforcement notified the Company on November 14, 2025 that it had concluded its investigation.
Based on the information available to the Division, it does not intend to recommend an enforcement action by the SEC against the Company. The SEC inquiry began with a request received on May 16, 2023 for the Company to voluntarily provide information. It was later augmented with a document subpoena and additional inquiries, and related primarily to the sourcing of non-human primates and related disclosures.
The Audit Committee had also retained counsel to conduct an independent investigation into certain issues raised in the SEC investigation. The Company stated that its independent investigation has also concluded, with no material findings. For investors, the filing indicates that the matter has been closed without an SEC enforcement recommendation and that the internal review identified no material findings.
02—Key points
Key Highlights
- The SEC Division of Enforcement concluded its investigation of the Company, notified on November 14, 2025.
- The Division does not intend to recommend an SEC enforcement action against the Company, based on information available to it.
- The investigation began with a voluntary information request received on May 16, 2023, later augmented by a document subpoena and additional inquiries.
- The inquiry related primarily to the sourcing of non-human primates and related disclosures.
- The Audit Committee-retained independent investigation into issues raised in the matter has also concluded, with no material findings.
- The disclosure is filed under Item 8.01 (Other Events) and does not report financial results or other quantitative figures.
03—Questions
Frequently Asked Questions
What did the SEC decide regarding Charles River Laboratories?
The SEC's Division of Enforcement notified the Company on November 14, 2025 that it had concluded its investigation and does not intend to recommend an enforcement action against the Company, based on the information available to the Division.
What was the SEC investigation about?
The investigation related primarily to the sourcing of non-human primates and related disclosures. It began with an inquiry received on May 16, 2023, which was later augmented with a document subpoena and additional inquiries.
Did the Company's own internal investigation find anything?
The Audit Committee retained counsel to conduct an independent investigation into certain issues raised in the SEC investigation. The Company stated that this investigation has also concluded, with no material findings.
Does this filing include any financial impact?
The filing does not report any financial figures, charges, or quantified impacts related to this matter.
04—Continue